ginsenoside rh2 has been researched along with Cardiotoxicity in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cui, C; Hou, J; Kim, S; Yun, Y | 1 |
1 other study(ies) available for ginsenoside rh2 and Cardiotoxicity
Article | Year |
---|---|
Ginsenoside Rh2 mitigates doxorubicin-induced cardiotoxicity by inhibiting apoptotic and inflammatory damage and weakening pathological remodelling in breast cancer-bearing mice.
Topics: Animals; Apoptosis; Breast Neoplasms; Cardiotoxicity; Doxorubicin; Endothelial Cells; Female; Ginsenosides; Humans; Mice; Mice, Nude; Myocytes, Cardiac; Necrosis; Oxidative Stress; RNA | 2022 |